UCB S.A. Stock
The UCB S.A. stock is trending slightly upwards today, with an increase of €0.20 (0.170%) compared to yesterday's price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for UCB S.A. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of UCB S.A. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of UCB S.A. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
UCB S.A. | 0.170% | -3.580% | 4.672% | 44.711% | 52.210% | 56.177% | 73.897% |
Bayer AG ADR | 6.620% | 9.848% | 7.407% | -49.301% | -15.698% | -45.896% | -52.614% |
Roche Holding AG ADR | 1.050% | 1.335% | 1.423% | -21.642% | -12.435% | -18.189% | - |
GSK plc ADR | 1.490% | 7.853% | 7.853% | 23.353% | 22.619% | 4.304% | -9.264% |
Comments
UCB SA (OTCMKTS: UCBJF) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating.
Show more
Ratings data for UCBJF provided by MarketBeat
UCB SA (OTCMKTS: UCBJF) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Show more
Ratings data for UCBJF provided by MarketBeat